跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,780 条关于
“GL-IL2-138”
全部
6,780
临床试验
4,989
药物
1,287
机构
7
资讯
497
去年
Genetic Leap Receives FDA IND Clearance for First-in-Class Oral IL-2 Modulator GL-IL2-138
去年
GL CHEMTEC Completes State-of-the-Art GMP Facility to Accelerate Clinical Trial Material Production
去年
UWM-Developed Drug, GL-Damonia, Enters FDA Phase 1 Trials for Depression and Alzheimer's
去年
Teva and Fosun Pharma Form Strategic Partnership for Novel Anti-PD1-IL2 Cancer Immunotherapy TEV-56278
去年
Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech for RNAi Therapeutics Development
4个月前
LTZ Therapeutics Secures $38 Million to Advance Universal Myeloid Cell Engager Immunotherapy Platform
11天前
Coya Therapeutics Publishes Preclinical Data Showing Complementary Immunomodulatory Effects of COYA 303 in Neuroinflammation Model
去年
Regeneron Appeals Eylea Biosimilar Ruling; Prime Therapeutics Adds Humira Biosimilars; Denosumab Biosimilar Advances
上个月
Obsidian Therapeutics Enrolls First Patient in Registration-Enabling Cohort for Amsoki-cel TIL Therapy in Advanced Melanoma
去年
EMA Accepts Alvotech's Biosimilar AVT03 for Prolia and Xgeva
第 1 页,共 50 页
上一页
下一页